Drug groups [BR:br08330]
Cardiovascular agent
DG01506 Arginine vasopressin receptor 2 (AVPR2) antagonist
D01855 Mozavaptane hydrochloride
Metabolizing enzyme substrate
DG02918 CYP2C8 substrate
D01855 Mozavaptane hydrochloride
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D01855 Mozavaptane hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Vasopressin
AVPR2
D01855 Mozavaptane hydrochloride (JAN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01855
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01855
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01855